{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:54:48Z","timestamp":1787496888470,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T00:00:00Z","timestamp":1416355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/pr.2014.183","type":"journal-article","created":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T11:55:40Z","timestamp":1416398140000},"page":"363-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adrenergic receptor genotype influences heart failure severity and \u03b2-blocker response in children with dilated cardiomyopathy"],"prefix":"10.1038","volume":"77","author":[{"given":"Sushma","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Manlhiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Seda","family":"Selamet Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Blume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth D.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Goldmuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Colan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Mital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,19]]},"reference":[{"key":"BFpr2014183_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1474-8673.1983.tb00496.x","volume":"3","author":"H Majewski","year":"1983","unstructured":"Majewski H . Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors. J Auton Pharmacol 1983;3:47\u201360.","journal-title":"J Auton Pharmacol"},{"key":"BFpr2014183_CR2","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/01.CIR.0000036600.39600.66","volume":"106","author":"M Brede","year":"2002","unstructured":"Brede M, Wiesmann F, Jahns R, et al. Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation 2002;106:2491\u20136.","journal-title":"Circulation"},{"key":"BFpr2014183_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0028-3908(95)00018-2","volume":"34","author":"L Hein","year":"1995","unstructured":"Hein L, Kobilka BK . Adrenergic receptor signal transduction and regulation. Neuropharmacology 1995;34:357\u201366.","journal-title":"Neuropharmacology"},{"key":"BFpr2014183_CR4","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.jacc.2004.07.058","volume":"44","author":"DM Kaye","year":"2004","unstructured":"Kaye DM, Smirk B, Finch S, Williams C, Esler MD . Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype. J Am Coll Cardiol 2004;44:2008\u201315.","journal-title":"J Am Coll Cardiol"},{"key":"BFpr2014183_CR5","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1056\/NEJMoa020803","volume":"347","author":"KM Small","year":"2002","unstructured":"Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB . Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002;347:1135\u201342.","journal-title":"N Engl J Med"},{"key":"BFpr2014183_CR6","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349\u201355.","journal-title":"N Engl J Med"},{"key":"BFpr2014183_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","volume":"298","author":"RE Shaddy","year":"2007","unstructured":"Shaddy RE, Boucek MM, Hsu DT, et al.; Pediatric Carvedilol Study Group. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007;298:1171\u20139.","journal-title":"JAMA"},{"key":"BFpr2014183_CR8","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.106.635128","volume":"114","author":"PE Daubeney","year":"2006","unstructured":"Daubeney PE, Nugent AW, Chondros P, et al.; National Australian Childhood Cardiomyopathy Study. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 2006;114:2671\u20138.","journal-title":"Circulation"},{"key":"BFpr2014183_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/46040","volume":"402","author":"L Hein","year":"1999","unstructured":"Hein L, Altman JD, Kobilka BK . Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 1999;402:181\u20134.","journal-title":"Nature"},{"key":"BFpr2014183_CR10","doi-asserted-by":"publisher","first-page":"23059","DOI":"10.1074\/jbc.M000796200","volume":"275","author":"KM Small","year":"2000","unstructured":"Small KM, Forbes SL, Rahman FF, Bridges KM, Liggett SB . A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem 2000;275:23059\u201364.","journal-title":"J Biol Chem"},{"issue":"3 Pt 1","key":"BFpr2014183_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/0002-8703(95)90360-7","volume":"130","author":"S Minatoguchi","year":"1995","unstructured":"Minatoguchi S, Ito H, Ishimura K, et al. Modulation of noradrenaline release through presynaptic alpha 2-adrenoceptors in congestive heart failure. Am Heart J 1995;130(3 Pt 1):516\u201321.","journal-title":"Am Heart J"},{"key":"BFpr2014183_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/sj.bjp.0705030","volume":"138","author":"AJ Sandilands","year":"2003","unstructured":"Sandilands AJ, O\u2019Shaughnessy KM, Brown MJ . Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 2003;138:386\u201392.","journal-title":"Br J Pharmacol"},{"key":"BFpr2014183_CR13","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ejheart.2004.10.006","volume":"7","author":"P de Groote","year":"2005","unstructured":"de Groote P, Lamblin N, Helbecque N, et al. The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure. Eur J Heart Fail 2005;7:966\u201373.","journal-title":"Eur J Heart Fail"},{"key":"BFpr2014183_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/00008571-200411000-00001","volume":"14","author":"K La Ros\u00e9e","year":"2004","unstructured":"La Ros\u00e9e K, Huntgeburth M, Rosenkranz S, B\u00f6hm M, Schnabel P . The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines. Pharmacogenetics 2004;14:711\u20136.","journal-title":"Pharmacogenetics"},{"key":"BFpr2014183_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.pharmtox.43.100901.135823","volume":"43","author":"KM Small","year":"2003","unstructured":"Small KM, McGraw DW, Liggett SB . Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 2003;43:381\u2013411.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFpr2014183_CR16","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1056\/NEJMoa010819","volume":"345","author":"V Dishy","year":"2001","unstructured":"Dishy V, Sofowora GG, Xie HG, et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001;345:1030\u20135.","journal-title":"N Engl J Med"},{"key":"BFpr2014183_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1056\/NEJM200202143460718","volume":"346","author":"SB Liggett","year":"2002","unstructured":"Liggett SB . Polymorphisms of the beta2-adrenergic receptor. N Engl J Med 2002;346:536\u20138.","journal-title":"N Engl J Med"},{"key":"BFpr2014183_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejheart.2005.07.009","volume":"8","author":"M Metra","year":"2006","unstructured":"Metra M, Zani C, Covolo L, et al. Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Eur J Heart Fail 2006;8:131\u20135.","journal-title":"Eur J Heart Fail"},{"key":"BFpr2014183_CR19","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/0735-1097(95)00332-0","volume":"26","author":"DM Kaye","year":"1995","unstructured":"Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD . Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995;26:1257\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"BFpr2014183_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0002-9149(84)90320-5","volume":"54","author":"DV Unverferth","year":"1984","unstructured":"Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV . Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147\u201352.","journal-title":"Am J Cardiol"},{"key":"BFpr2014183_CR21","first-page":"756","volume":"12","author":"C Campana","year":"1993","unstructured":"Campana C, Gavazzi A, Berzuini C, et al. Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Transplant 1993;12:756\u201365.","journal-title":"J Heart Lung Transplant"},{"key":"BFpr2014183_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0002-9149(94)90012-4","volume":"73","author":"D Morley","year":"1994","unstructured":"Morley D, Brozena SC . Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation. Am J Cardiol 1994;73:379\u201383.","journal-title":"Am J Cardiol"},{"key":"BFpr2014183_CR23","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/0002-9149(90)91166-4","volume":"66","author":"LW Stevenson","year":"1990","unstructured":"Stevenson LW, Tillisch JH, Hamilton M, et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990;66:1348\u201354.","journal-title":"Am J Cardiol"},{"key":"BFpr2014183_CR24","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","volume":"41","author":"A Nohria","year":"2003","unstructured":"Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003;41:1797\u2013804.","journal-title":"J Am Coll Cardiol"},{"key":"BFpr2014183_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819\u201323.","journal-title":"N Engl J Med"},{"issue":"3 Pt 2","key":"BFpr2014183_CR26","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1164\/ajrccm.161.supplement_2.a1q4-10","volume":"161","author":"SB Liggett","year":"2000","unstructured":"Liggett SB . beta(2)-adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med 2000;161(3 Pt 2):S197\u2013201.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFpr2014183_CR27","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1023\/A:1021477021102","volume":"19","author":"JA Johnson","year":"2002","unstructured":"Johnson JA, Terra SG . Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharm Res 2002;19:1779\u201387.","journal-title":"Pharm Res"},{"key":"BFpr2014183_CR28","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/nm930","volume":"9","author":"J Mialet Perez","year":"2003","unstructured":"Mialet Perez J, Rathz DA, Petrashevskaya NN, et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 2003;9:1300\u20135.","journal-title":"Nat Med"},{"key":"BFpr2014183_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/FPC.0b013e3280105245","volume":"17","author":"MT Lobmeyer","year":"2007","unstructured":"Lobmeyer MT, Gong Y, Terra SG, et al. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure. Pharmacogenet Genomics 2007;17:277\u201382.","journal-title":"Pharmacogenet Genomics"},{"key":"BFpr2014183_CR30","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jacc.2008.05.022","volume":"52","author":"AJ Sehnert","year":"2008","unstructured":"Sehnert AJ, Daniels SE, Elashoff M, et al. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. J Am Coll Cardiol 2008;52:644\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"BFpr2014183_CR31","doi-asserted-by":"publisher","first-page":"11288","DOI":"10.1073\/pnas.0509937103","volume":"103","author":"SB Liggett","year":"2006","unstructured":"Liggett SB, Mialet-Perez J, Thaneemit-Chen S, et al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci USA 2006;103:11288\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2014183_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCHEARTFAILURE.109.885962","volume":"3","author":"MR Bristow","year":"2010","unstructured":"Bristow MR, Murphy GA, Krause-Steinrauf H, et al. An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure. Circ Heart Fail 2010;3:21\u20138.","journal-title":"Circ Heart Fail"},{"key":"BFpr2014183_CR33","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1161\/01.CIR.102.15.1814","volume":"102","author":"P Molenaar","year":"2000","unstructured":"Molenaar P, Bartel S, Cochrane A, et al. Both beta(2)- and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-protein. Circulation 2000;102:1814\u201321.","journal-title":"Circulation"},{"key":"BFpr2014183_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-003-0824-2","volume":"369","author":"K Leineweber","year":"2004","unstructured":"Leineweber K, B\u00fcscher R, Bruck H, Brodde OE . Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 2004;369:1\u201322.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFpr2014183_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<271::AID-HUMU14>3.0.CO;2-Q","volume":"14","author":"JD Moore","year":"1999","unstructured":"Moore JD, Mason DA, Green SA, Hsu J, Liggett SB . Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A&gt;G and c1165G&gt;C. Hum Mutat 1999;14:271.","journal-title":"Hum Mutat"},{"key":"BFpr2014183_CR36","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.echo.2012.05.004","volume":"25","author":"SD Colan","year":"2012","unstructured":"Colan SD, Shirali G, Margossian R, et al. The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr 2012;25:842\u201354.e6.","journal-title":"J Am Soc Echocardiogr"},{"key":"BFpr2014183_CR37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0735-1097(02)02921-2","volume":"41","author":"M Wang","year":"2003","unstructured":"Wang M, Yip GW, Wang AY, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 2003;41:820\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"BFpr2014183_CR38","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1161\/01.STR.0000177482.23478.dc","volume":"36","author":"HP Grocott","year":"2005","unstructured":"Grocott HP, White WD, Morris RW, et al.; Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team. Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke 2005;36:1854\u20138.","journal-title":"Stroke"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2014183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2014183","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2014183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T01:01:41Z","timestamp":1684458101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2014183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,19]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFpr2014183"],"URL":"https:\/\/doi.org\/10.1038\/pr.2014.183","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,19]]},"assertion":[{"value":"17 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}